
Zilfur Pharma Private Limited
About Zilfur Pharma Private Limited
Data last updated:
Zilfur Pharma Private Limited was a private limited company based in Pune, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 August 2017.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC171833. Its GSTIN is 27AABCZ1148C1ZL (Maharashtra).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sagar Ramakant Lodha and Aniket Ashok Misar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Fl No. G – H – 601 Gat No. 87 To 90 Dsk Meghmalhar Dsk Vishwa, Pune, Maharashtra, India – 411041.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.63 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹2.91 Lakh (net margin -43.9%) and EBITDA of -₹2.84 Lakh (EBITDA margin -42.8%).
Company details
Contact details
Zilfur Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFl No. G – H – 601 Gat No. 87 To 90 Dsk Meghmalhar Dsk Vishwa, Pune, Maharashtra, India – 411041
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zilfur Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zilfur Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Zilfur Pharma Private Limited, buy the company report.
Financials of Zilfur Pharma Private Limited
FY 2022 filings availableZilfur Pharma Private Limited reported revenue of ₹6.63 Lakh (down 23% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year. EBITDA fell 325% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹6.63 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -42.8% | ||||
| Net Profit Margin | -43.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zilfur Pharma Private Limited, buy the company report.
Board of directors of Zilfur Pharma Private Limited
Zilfur Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sagar Ramakant Lodha | Director | 03 Aug 2017 | 9 Years 3 Months | As last reported |
| Aniket Ashok Misar Also directs: Pulse Medicare & Research Private Limited | Director | 03 Aug 2017 | 9 Years 3 Months | As last reported |
Peer comparison
Zilfur Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Roshni Health Care Private Limited | ₹6.7 Lakh (FY 2022) | -52.0% | Pune, Maharashtra, India | |||
| Carekart Cure at Home Private Limited | ₹6.67 Lakh (FY 2025) | -40.0% | Jaipur, Rajasthan, India | |||
| MJ Multispeciality Hospicare Private Limited | ₹6.66 Lakh (FY 2024) | -4.0% | Bhubaneswar, Odisha, India | |||
| Dr GPS Medicare Private Limited | ₹6.64 Lakh (FY 2025) | -47.0% | Jaunpur, Uttar Pradesh, India | |||
| Avanzar Pharmaceutical Private Limited | ₹6.64 Lakh (FY 2025) | 32.0% | New Delhi, Delhi, India | |||
| Zilfur Pharma Private Limitedthis company | ₹6.63 Lakh (FY 2022) | -₹2.91 Lakh | -43.9% | -23.0% | Pune, Maharashtra, India | |
| Deepfacts Private Limited | ₹6.62 Lakh (FY 2024) | 66.0% | Hyderabad, Telangana, India | |||
| Ratan Dularo Hospital Private Limited | ₹6.6 Lakh (FY 2019) | Etah, Uttar Pradesh, India | ||||
| Wayzina Pharmaceuticals Private Limited | ₹6.58 Lakh (FY 2025) | -22.0% | Patna, Bihar, India | |||
| Sabra Medicare Private Limited | ₹6.58 Lakh (FY 2025) | 168.0% | Uttar Pradesh, India | |||
| VR Upchar Private Limited | ₹6.58 Lakh (FY 2025) | -47.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Zilfur Pharma Private Limited, buy the company report.
Auditor
Zilfur Pharma Private Limited is audited by S B OHARA AND COMPANY for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S B OHARA AND COMPANY | FY 2021 | 131804W |
Shareholding
The shareholding of Zilfur Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Zilfur Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zilfur Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zilfur Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zilfur Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCZ1148C1ZL | Maharashtra | Active | 10 Nov 2017 |
To see the full GST registrations and return filing status of Zilfur Pharma Private Limited, buy the company report.
Recent activity
Zilfur Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Aniket Ashok Misar was appointed as Director on 03 Aug 2017.
Frequently asked questions
Zilfur Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Zilfur Pharma was a private limited company based in Pune, Maharashtra, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 August 2017 and is registered under CIN U74999PN2017PTC171833. The company has been struck off by the Registrar of Companies and is no longer operational.
Zilfur Pharma had 2 directors:
- Sagar Ramakant Lodha - Director
- Aniket Ashok Misar - Director
The CIN (Corporate Identification Number) of Zilfur Pharma is U74999PN2017PTC171833. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Zilfur Pharma is at Fl No. G – H – 601 Gat No. 87 To 90 Dsk Meghmalhar Dsk Vishwa, Pune, Maharashtra, India – 411041.
Zilfur Pharma was incorporated on 03 August 2017. It is registered with the Registrar of Companies, Pune.
The latest financial statements of Zilfur Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Zilfur Pharma is 27AABCZ1148C1ZL, registered in Maharashtra.
Zilfur Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Zilfur Pharma by revenue are Roshni Health Care Private Limited, Carekart Cure at Home Private Limited, MJ Multispeciality Hospicare Private Limited, Dr GPS Medicare Private Limited, Avanzar Pharmaceutical Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Aniket Ashok Misar was appointed as Director on 03 Aug 2017. Sagar Ramakant Lodha was appointed as Director on 03 Aug 2017.

